Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

IO Biotech's co-founder presented advancements in cancer vaccines at ... The company is headquartered in Copenhagen with a U.S. office in New York. Dr. Mads Hald Andersen’s prominence in the ...

At this year's South by Southwest (SXSW) conference in Austin, Texas, Future Today Strategy Group founder and CEO Amy Webb ...

Fueled by a unique blend of innovation, talent, and collaboration, Austin has built a reputation as a tech powerhouse, but ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Protein Engineering Market IntroductionThe protein engineering market is rapidly evolving, driven by the need to develop proteins with improved functionality for a range of applications, including ...

Every day brings new technological developments that affect every aspect of our lives, writing the future. New developments ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...